Masimo ROE 2010-2025 | MASI
Current and historical return on equity (ROE) values for Masimo (MASI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Masimo ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.50B | $0.95B | -40.99% |
| 2024-12-31 | $-0.31B | $1.05B | -23.24% |
| 2024-09-30 | $0.08B | $1.46B | 5.68% |
| 2024-06-30 | $0.08B | $1.37B | 5.95% |
| 2024-03-31 | $0.08B | $1.37B | 6.02% |
| 2023-12-31 | $0.08B | $1.37B | 6.21% |
| 2023-09-30 | $0.09B | $1.28B | 6.78% |
| 2023-06-30 | $0.12B | $1.31B | 8.87% |
| 2023-03-31 | $0.12B | $1.33B | 9.21% |
| 2022-12-31 | $0.14B | $1.34B | 10.71% |
| 2022-09-30 | $0.17B | $1.25B | 12.24% |
| 2022-06-30 | $0.19B | $1.20B | 13.17% |
| 2022-03-31 | $0.22B | $1.58B | 14.89% |
| 2021-12-31 | $0.23B | $1.55B | 15.97% |
| 2021-09-30 | $0.23B | $1.47B | 16.59% |
| 2021-06-30 | $0.22B | $1.39B | 16.10% |
| 2021-03-31 | $0.23B | $1.33B | 16.67% |
| 2020-12-31 | $0.24B | $1.41B | 17.71% |
| 2020-09-30 | $0.22B | $1.42B | 17.14% |
| 2020-06-30 | $0.22B | $1.35B | 18.22% |
| 2020-03-31 | $0.21B | $1.25B | 18.47% |
| 2019-12-31 | $0.20B | $1.17B | 18.14% |
| 2019-09-30 | $0.19B | $1.11B | 18.44% |
| 2019-06-30 | $0.20B | $1.04B | 20.17% |
| 2019-03-31 | $0.20B | $1.01B | 21.23% |
| 2018-12-31 | $0.19B | $0.97B | 22.34% |
| 2018-09-30 | $0.14B | $0.91B | 17.22% |
| 2018-06-30 | $0.12B | $0.83B | 15.56% |
| 2018-03-31 | $0.12B | $0.77B | 16.32% |
| 2017-12-31 | $0.13B | $0.72B | 17.96% |
| 2017-09-30 | $0.36B | $0.72B | 54.81% |
| 2017-06-30 | $0.35B | $0.71B | 62.79% |
| 2017-03-31 | $0.34B | $0.63B | 73.77% |
| 2016-12-31 | $0.31B | $0.56B | 85.71% |
| 2016-09-30 | $0.11B | $0.33B | 37.54% |
| 2016-06-30 | $0.10B | $0.30B | 36.50% |
| 2016-03-31 | $0.09B | $0.27B | 32.85% |
| 2015-12-31 | $0.08B | $0.28B | 28.79% |
| 2015-09-30 | $0.08B | $0.27B | 27.00% |
| 2015-06-30 | $0.08B | $0.28B | 25.31% |
| 2015-03-31 | $0.07B | $0.33B | 22.98% |
| 2014-12-31 | $0.07B | $0.31B | 23.10% |
| 2014-09-30 | $0.06B | $0.28B | 19.03% |
| 2014-06-30 | $0.06B | $0.32B | 18.90% |
| 2014-03-31 | $0.07B | $0.35B | 20.22% |
| 2013-12-31 | $0.06B | $0.33B | 19.11% |
| 2013-09-30 | $0.06B | $0.31B | 21.99% |
| 2013-06-30 | $0.06B | $0.29B | 21.31% |
| 2013-03-31 | $0.06B | $0.28B | 21.61% |
| 2012-12-31 | $0.06B | $0.28B | 21.67% |
| 2012-09-30 | $0.06B | $0.31B | 21.25% |
| 2012-06-30 | $0.06B | $0.30B | 21.91% |
| 2012-03-31 | $0.06B | $0.28B | 21.87% |
| 2011-12-31 | $0.06B | $0.28B | 23.04% |
| 2011-09-30 | $0.07B | $0.30B | 24.88% |
| 2011-06-30 | $0.07B | $0.28B | 26.51% |
| 2011-03-31 | $0.06B | $0.26B | 26.69% |
| 2010-12-31 | $0.07B | $0.23B | 31.98% |
| 2010-09-30 | $0.07B | $0.25B | 29.19% |
| 2010-06-30 | $0.07B | $0.23B | 27.28% |
| 2010-03-31 | $0.07B | $0.21B | 26.17% |
| 2009-12-31 | $0.05B | $0.29B | 20.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.338B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $176.546B | 21.36 |
| Intuitive Surgical (ISRG) | United States | $172.459B | 71.48 |
| Edwards Lifesciences (EW) | United States | $46.523B | 30.86 |
| Alcon (ALC) | Switzerland | $43.184B | 29.18 |
| IDEXX Laboratories (IDXX) | United States | $42.970B | 49.38 |
| DexCom (DXCM) | United States | $31.674B | 47.51 |
| IQVIA Holdings (IQV) | United States | $31.596B | 17.85 |
| Mettler-Toledo (MTD) | United States | $25.639B | 30.16 |
| STERIS (STE) | Ireland | $22.280B | 24.54 |
| Waters (WAT) | United States | $17.184B | 24.25 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.216B | 0.00 |
| Hologic (HOLX) | United States | $14.891B | 16.10 |
| Sysmex ADR (SSMXY) | Japan | $10.273B | 29.14 |
| Penumbra (PEN) | United States | $9.838B | 71.87 |
| Globus Medical (GMED) | United States | $7.125B | 16.98 |
| Teleflex (TFX) | United States | $5.281B | 8.52 |
| Glaukos (GKOS) | United States | $4.919B | 0.00 |
| TransMedics (TMDX) | United States | $4.056B | 61.64 |
| Integer Holdings (ITGR) | United States | $3.802B | 18.97 |
| PROCEPT BioRobotics (PRCT) | United States | $2.684B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.300B | 13.70 |
| Nihon Kohden (NHNKY) | Japan | $1.918B | 22.00 |
| Elekta AB (EKTAY) | Sweden | $1.864B | 16.76 |
| Veracyte (VCYT) | United States | $1.841B | 25.83 |
| Alphatec Holdings (ATEC) | United States | $1.547B | 0.00 |
| Artivion (AORT) | United States | $1.320B | 123.64 |
| Tandem Diabetes Care (TNDM) | United States | $1.038B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.021B | 5.87 |
| OPKO Health (OPK) | United States | $1.015B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.010B | 0.00 |
| IRadimed (IRMD) | United States | $0.742B | 37.64 |
| Beta Bionics (BBNX) | United States | $0.730B | 0.00 |
| SiBone (SIBN) | United States | $0.726B | 0.00 |
| AxoGen (AXGN) | United States | $0.596B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.517B | 8.04 |
| OrthoPediatrics (KIDS) | United States | $0.503B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.494B | 10.64 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.421B | 9.78 |
| Pacific Biosciences Of California (PACB) | United States | $0.414B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.374B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.360B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.338B | 0.00 |
| RxSight (RXST) | United States | $0.316B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.291B | 0.00 |
| Neuronetics (STIM) | United States | $0.290B | 0.00 |
| NeuroPace (NPCE) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.06 |
| CVRx (CVRX) | United States | $0.208B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.172B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Accuray (ARAY) | United States | $0.148B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.092B | 55.90 |
| InspireMD (NSPR) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.081B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 20.33 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.48 |